Delaware | 001-04298 | 95-1934119 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
12367 Crosthwaite Circle, Poway, California |
92064 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits. |
Cohu, Inc. |
||||
October 22, 2009 | By: | Jeffrey D. Jones | ||
Name: | Jeffrey D. Jones | |||
Title: | VP Finance and Chief Financial Officer |
Exhibit No. | Description | |||
99.1 | Third Quarter 2009 Earnings Release, dated October 21, 2009, of Cohu, Inc. |
Three Months Ended (1) | Nine Months Ended (1) | |||||||||||||||
September 26, | September 27, | September 26, | September 27, | |||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
Net sales |
$ | 44,062 | $ | 48,016 | $ | 119,068 | $ | 158,258 | ||||||||
Cost and expenses: |
||||||||||||||||
Cost of sales |
27,845 | 30,458 | 83,128 | 101,453 | ||||||||||||
Research and development |
8,284 | 9,140 | 24,022 | 29,582 | ||||||||||||
Selling, general and administrative |
8,731 | 9,693 | 26,431 | 27,652 | ||||||||||||
44,860 | 49,291 | 133,581 | 158,687 | |||||||||||||
Loss from operations |
(798 | ) | (1,275 | ) | (14,513 | ) | (429 | ) | ||||||||
Interest and other, net (2) |
302 | 1,391 | 1,128 | 4,282 | ||||||||||||
Income (loss) before income taxes |
(496 | ) | 116 | (13,385 | ) | 3,853 | ||||||||||
Income tax provision (benefit) (3) |
(425 | ) | 79 | 15,553 | 1,690 | |||||||||||
Net income (loss) |
$ | (71 | ) | $ | 37 | $ | (28,938 | ) | $ | 2,163 | ||||||
Income (loss) per share: |
||||||||||||||||
Basic |
$ | (0.00 | ) | $ | 0.00 | $ | (1.24 | ) | $ | 0.09 | ||||||
Diluted |
$ | (0.00 | ) | $ | 0.00 | $ | (1.24 | ) | $ | 0.09 | ||||||
Weighted average shares used in
computing income (loss) per share (4): |
||||||||||||||||
Basic |
23,429 | 23,233 | 23,384 | 23,142 | ||||||||||||
Diluted |
23,429 | 23,477 | 23,384 | 23,380 | ||||||||||||
(1) | The three- and nine-month periods ended September 26, 2009 and September 27, 2008 each contain 13 weeks and 39 weeks, respectively. Total share-based compensation recorded in the three-month period ended September 26, 2009 was approximately $924,000 and is included in cost of sales ($94,000); research and development ($351,000); and selling, general and administrative expense ($479,000). Total share-based compensation recorded in the nine-month period ended September 27, 2009 was approximately $2,474,000 and is included in cost of sales ($241,000); research and development ($825,000); and selling, general and administrative expense ($1,408,000). Total share-based compensation recorded in the three-month period ended September 26, 2008 was approximately $1,094,000 and is included in cost of sales ($88,000); research and development ($331,000); and selling, general and administrative expense ($675,000). Total share-based compensation recorded in the nine-month period ended September 27, 2008 was approximately $3,188,000 and is included in cost of sales ($266,000); research and development ($951,000); and selling, general and administrative expense ($1,971,000). | |
(2) | The nine-month period ended September 27, 2008 includes a short-term investment loss of $350,000 recorded in the first fiscal quarter. | |
(3) | During the second quarter of 2009, the Company recorded a charge of $19.6 million for an increase in the valuation allowance against deferred tax assets. | |
(4) | For the three- and nine-month periods ended September 26, 2009, potentially dilutive securities were excluded from the per share computations due to their antidilutive effect. |
September 26, | December 27, | |||||||
2009 | 2008 | |||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash and investments |
$ | 87,273 | $ | 88,385 | ||||
Accounts receivable |
34,898 | 31,945 | ||||||
Inventories |
51,202 | 53,314 | ||||||
Deferred taxes and other |
10,049 | 25,620 | ||||||
Total current assets |
183,422 | 199,264 | ||||||
Property, plant & equipment, net |
38,541 | 39,429 | ||||||
Goodwill |
62,492 | 60,820 | ||||||
Intangible assets, net |
37,776 | 40,993 | ||||||
Other assets |
1,407 | 3,663 | ||||||
Total assets |
$ | 323,638 | $ | 344,169 | ||||
Liabilities & Stockholders Equity: |
||||||||
Current liabilities: |
||||||||
Deferred profit |
$ | 5,134 | $ | 4,434 | ||||
Other current liabilities |
42,124 | 39,241 | ||||||
Total current liabilities |
47,258 | 43,675 | ||||||
Deferred taxes and other noncurrent liabilities |
17,895 | 14,955 | ||||||
Stockholders equity |
258,485 | 285,539 | ||||||
Total liabilities & stockholders equity |
$ | 323,638 | $ | 344,169 | ||||
Three Months Ended | ||||||||||||
September 26, | September 27, | June 27, | ||||||||||
2009 | 2008 | 2009 | ||||||||||
Loss from operations GAAP basis (a) |
$ | (798 | ) | $ | (1,275 | ) | $ | (4,100 | ) | |||
Non-GAAP adjustments: |
||||||||||||
Share-based compensation included in (b): |
||||||||||||
Costs of goods sold |
94 | 88 | 89 | |||||||||
Research and development |
351 | 331 | 270 | |||||||||
Selling, general and administrative |
479 | 675 | 483 | |||||||||
924 | 1,094 | 842 | ||||||||||
Amortization of intangible assets included in (c): |
||||||||||||
Costs of goods sold |
1,364 | 463 | 1,311 | |||||||||
Research and development |
| | | |||||||||
Selling, general and administrative |
216 | 48 | 208 | |||||||||
1,580 | 511 | 1,519 | ||||||||||
Income (loss) from operations non-GAAP basis (d) |
$ | 1,706 | $ | 330 | $ | (1,739 | ) | |||||
Net income (loss) GAAP basis |
$ | (71 | ) | $ | 37 | $ | (22,605 | ) | ||||
Non-GAAP adjustments (as scheduled above) |
2,504 | 1,605 | 2,361 | |||||||||
Tax effect of non-GAAP adjustments (e) |
(756 | ) | (457 | ) | (682 | ) | ||||||
Non-cash increase of valuation allowance (f) |
| | 19,551 | |||||||||
Net income (loss) non-GAAP basis |
$ | 1,677 | $ | 1,185 | $ | (1,375 | ) | |||||
GAAP net loss per share diluted |
$ | (0.00 | ) | $ | 0.00 | $ | (0.97 | ) | ||||
Non-GAAP net income (loss) per share diluted (g) |
$ | 0.07 | $ | 0.05 | $ | (0.06 | ) |
Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Companys operating performance. Our management uses these non-GAAP financial measures in assessing the Companys operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Companys financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Companys operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Additionally, management does not consider charges to the deferred tax valuation allowance as related to the Companys operational performance and, as such, has excluded them to provide a better understanding of the companys underlying operational results and a more meaningful basis for comparison with our historical and future results. However, the non-GAAP financial measures should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures. The presentation of non-GAAP financial measures above may not be comparable to similarly titled measures reported by other companies and investors should be careful when comparing our non-GAAP financial measures to those of other companies. | ||
(a) | (1.8)%, (2.7)% and (10.7)% of net sales, respectively. | |
(b) | To eliminate compensation expense for employee stock options, restricted stock units and our employee stock purchase plan. | |
(c) | To eliminate the amortization of intangible assets acquired in the fiscal 2008 acquisition of Rasco, the fiscal 2007 acquisition of Tandberg Television AVS GmbH and the fiscal 2006 acquisition of Unigen. | |
(d) | 3.9%, 0.7% and (4.5)% of net sales, respectively. | |
(e) | To adjust the provision (benefit) for income taxes related to the adjustments described in notes (b) and (c) above based on applicable tax rates. | |
(f) | To exclude the non-cash net impact on the tax provision pertaining to the increase of the deferred asset valuation allowance. | |
(g) | Computed using 23,631, 23,477 and 23,381 diluted shares outstanding for the three-month periods ended September 26, 2009 September 27, 2008 and June 27, 2009, respectively. For the three-month period ended September 26, 2009 the effect of dilutive securities was excluded from GAAP diluted common shares due to the reported net loss under GAAP, but are included for non-GAAP diluted common shares since the Company has non-GAAP net income. |
Nine Months Ended | ||||||||
September 26, | September 27, | |||||||
2009 | 2008 | |||||||
Loss from operations GAAP basis (a) |
$ | (14,513 | ) | $ | (429 | ) | ||
Non-GAAP adjustments: |
||||||||
Share-based compensation included in (b): |
||||||||
Costs of goods sold |
241 | 266 | ||||||
Research and development |
825 | 951 | ||||||
Selling, general and administrative |
1,408 | 1,971 | ||||||
2,474 | 3,188 | |||||||
Amortization of intangible assets included in (c): |
||||||||
Costs of goods sold |
3,978 | 1,611 | ||||||
Research and development |
| | ||||||
Selling, general and administrative |
631 | 145 | ||||||
4,609 | 1,756 | |||||||
Income (loss) from operations non-GAAP basis (d) |
$ | (7,430 | ) | $ | 4,515 | |||
Net income (loss) GAAP basis |
$ | (28,938 | ) | $ | 2,163 | |||
Non-GAAP adjustments (as scheduled above) |
7,083 | 4,944 | ||||||
Tax effect of non-GAAP adjustments (e) |
(2,143 | ) | (1,450 | ) | ||||
Non-cash increase of valuation allowance (f) |
19,551 | | ||||||
Net income (loss) non-GAAP basis |
$ | (4,447 | ) | $ | 5,657 | |||
GAAP net income (loss) per share diluted |
$ | (1.24 | ) | $ | 0.09 | |||
Non-GAAP net income (loss) per share diluted (g) |
$ | (0.19 | ) | $ | 0.24 |
Management believes the presentation of these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding the Companys operating performance. Our management uses these non-GAAP financial measures in assessing the Companys operating results, as well as when planning, forecasting and analyzing future periods and these non-GAAP measures allow investors to evaluate the Companys financial performance using some of the same measures as management. Management views share-based compensation as an expense that is unrelated to the Companys operational performance as it does not require cash payments and can vary in amount from period to period and the elimination of amortization charges provides better comparability of pre and post-acquisition operating results and to results of businesses utilizing internally developed intangible assets. Additionally, management does not consider charges to the deferred tax valuation allowance as related to the Companys operational performance and, as such, has excluded them to provide a better understanding of the companys underlying operational results and a more meaningful basis for comparison with our historical and future results. However, the non-GAAP financial measures should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures. The presentation of non-GAAP financial measures above may not be comparable to similarly titled measures reported by other companies and investors should be careful when comparing our non-GAAP financial measures to those of other companies. | ||
(a) | (12.2)% and (0.3)% of net sales, respectively. | |
(b) | To eliminate compensation expense for employee stock options, restricted stock units and our employee stock purchase plan. | |
(c) | To eliminate the amortization of intangible assets acquired in the fiscal 2008 acquisition of Rasco, the fiscal 2007 acquisition of Tandberg Television AVS GmbH, the fiscal 2006 acquisition of Unigen and the fiscal 2005 acquisition of KryoTech. | |
(d) | (6.2)% and 2.9% of net sales, respectively. | |
(e) | To adjust the provision (benefit) for income taxes related to the adjustments described in notes (b) and (c) above based on applicable tax rates. | |
(f) | To exclude the non-cash net impact on the tax provision pertaining to the increase of the deferred tax asset valuation allowance. | |
(g) | Computed using number of GAAP diluted shares outstanding for each period presented. |